LSD, Urine - Screen with Reflex to Confirmation/Quantitation
Also known as: LSD URN
Use
The LSD, Urine - Screen with Reflex to Confirmation/Quantitation test is designed to detect the presence of Lysergic Acid Diethylamide (LSD) in urine samples. It serves an important role in clinical toxicology by helping to identify potential LSD use or exposure, thus providing crucial information for clinical management and treatment plans for individuals suspected of substance use.
Special Instructions
This test is not performed at ARUP Laboratories; it is conducted by NMS Labs. A positive screening result triggers reflex testing for confirmation using advanced methodologies, and additional charges will apply. Specimen collection for multiple tests may require separate submissions.
Limitations
This test was developed and validated by NMS Labs and is not cleared or approved by the U.S. Food and Drug Administration. As with any test of this nature, it is possible for false positives or negatives to occur. Reflex testing will provide confirmation to improve accuracy when initial screening results are positive. It is important to note that test performance can vary based on the context of specimen collection and handling practices.
New York Approved
Methodology
Immunoassay (ELISA)
Biomarkers
LOINC Codes
- 19528-9
Result Turnaround Time
7-13 days
Related Documents
For more information, please review the documents below
Specimen
Urine
Volume
2 mL
Minimum Volume
0.9 mL
Container
ARUP standard transport tube
Collection Instructions
Transfer 2 mL urine to an ARUP standard transport tube.
Storage Instructions
Refrigerated. Also acceptable: Frozen.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 24 hours |
| Refrigerated | 1 month |
| Frozen | 1 month |